20160128 EGA Regulatory and Scientific Affairs Conferenc

Better access to medicines in Bulgaria prioritised by Medicines for Europe President

16 December 2019

Christoph Stoller, the President of Medicines for Europe, led an […]

Read more

Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe

28 November 2019

The European Commission has identified the use of generic and […]

Read more

Open letter from Medicines for Europe Executive on medicines shortages

26 November 2019


European industries unite to call for an ambitious EU industrial strategy

26 November 2019


Biosimilar medicines: competition, sustainability and early* access on the agenda of DG GROW stakeholder workshop

30 October 2019

Medicines for Europe welcomes 5th European Commission Stakeholder event on […]

Read more

WHO signs MoU with International Generic and Biosimilar Medicines Association to promote access

23 October 2019


Report identifies 9 key ingredients to improve access to medicines in the hospital setting

7 October 2019

Many European countries are grappling with the efficiency of hospital […]

Read more

EU manufacturers call for urgent reforms to achieve reciprocity and a level-playing field in public procurement

30 September 2019

Brussels, 30 September 2019 – Amidst discussions on the International […]

Read more

Christoph Stoller (Teva) Appointed as new President of Medicines for Europe
Immediately calls on new President of EU Commission to prioritise Healthcare

25 September 2019

Christoph Stoller was elected as President of Medicines for Europe […]

Read more

Ready to drive access to medicines

21 June 2019

Medicines for Europe is ready to engage with the EU […]

Read more

Subscribe to our newsletter